Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety and Efficacy Study of NBI-56418 in Endometriosis (PETAL)
This study has been completed.
Study NCT00437658   Information provided by Neurocrine Biosciences
First Received: February 16, 2007   Last Updated: September 28, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Endometriosis
More general conditions related to this trial
Genital Diseases, Female
Interventions listed in this trial
NBI-56418
depo-subQ provera 104
Additional drug interventions recognized in this trial
Medroxyprogesterone
Medroxyprogesterone 17-Acetate
More general drug interventions related to this trial
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Contraceptive Agents
Contraceptive Agents, Female
Contraceptive Agents, Male
Contraceptives, Oral
Contraceptives, Oral, Synthetic
Pharmacologic Actions
Physiological Effects of Drugs
Reproductive Control Agents
Therapeutic Uses
Sponsors listed in this trial
Neurocrine Biosciences


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services